Hong Kong Public Offering �C White Form eIPO Service Provider Application Form 香港公开发售－白表eIPO服务供应商申请表格 Please use this application form if you are a White Form eIPO Service Provider and are applying for Hong Kong Public Offer Shares on behalf of underlying applicants. 倘　阁下为白表eIPO服务供应商并代表相关申请人申请认购香港公开发售股份，请使用本申请表格。 1 We confirm that we have (i) complied with the Guidelines for Electronic Public Offerings and the Operational Procedures for White Form eIPO applications submitted via banks/ stockbrokers and all applicable laws and regulations (whether statutory or otherwise) in relation to the provision of our White Form eIPO services in connection with the Hong Kong Public Offering; and (ii) read the terms and conditions and application procedures set out in the Prospectus and this Application Form and agree to be bound by them. Applying on behalf of each of the underlying applicants to whom this application relates, we: apply for the number of Hong Kong Public Offer Shares set out below, on the terms and conditions of the Prospectus and this Application Form, and subject to the Articles of Association of the Company; enclose payment in full for the Hong Kong Public Offer Shares applied for, including 1% brokerage fee, 0.0027% SFC transaction levy and 0.005% Hong Kong Stock Exchange trading fee; confirm that the underlying applicants have undertaken and agreed to accept the Hong Kong Public Offer Shares applied for, or any lesser number allocated to such underlying applicants on this application; undertake and confirm that the underlying applicant(s) and the person for whose benefit the underlying applicant(s) is/are applying has/have not applied for or taken up, or indicated an interest for, or received or been placed or allocated (including conditionally and/or provisionally), and will not apply for or take up, or indicate an interest for, any Offer Shares under the International Offering nor otherwise participate in the International Offering; understand that these declarations and representations will be relied upon by the Company and the Joint Global Coordinators in deciding whether or not to make any allotment of Hong Kong Public Offer Shares in response to this application, and that the underlying applicants may be prosecuted if they made a false declaration; authorize the Company to place the name(s) of the underlying applicant(s) on the register of members of the Company as the holder(s) of any Hong Kong Public Offer Shares to be allotted to them, and the Company and/or its agents to send any share certificate(s) (where applicable) by ordinary post at that underlying applicant’s own risk to the address specified in the application instruction of that underlying applicant in accordance with the procedures prescribed in this Application Form and in the Prospectus; request that any e-Refund payment instructions be dispatched to the application payment account where the applicants had paid the application monies from a single bank account; request that any refund cheque(s) be made payable to the underlying applicant(s) who had used multiple bank accounts to pay the application monies; confirm that each underlying applicant has read the terms and conditions and application procedures set out in this Application Form and in the Prospectus and agree to be bound by them; represent, warrant and undertake that the allotment of or application for the Hong Kong Public Offer Shares to the underlying applicant or by underlying applicant or for whose benefit this application is made would not require the Company, the Joint Global Coordinators, the Underwriters or their respective officers or advisers to comply with any requirements under any law or regulation (whether or not having the force of law) of any territory outside Hong Kong; and agree that this application, any acceptance of it and the resulting contract, will be governed by and construed in accordance with the laws of Hong Kong. 3 Total of cheques Cheque number(s) 现夹附合共 张支票 支票号码 are enclosed for HK$ a total sum of 总金额为 港元 Please use BLOCK letters 请用正楷填写 4 Name of White Form eIPO Service Provider 白表 eIPO服务供应商名称 Chinese Name White Form eIPO Service Provider ID 中文名称 白表eIPO服务供应商身份证明号码 Name of contact person Contact number Fax number 联络人名称 联络电话号码 传真号码 Address 地址 For Broker use 此栏供经纪填写 Lodged by 申请由以下经纪递交 Broker No. 经纪号码 Broker’s Chop 经纪印章 2 We, on behalf of the Total number of Shares Hong Kong Public Offer Shares on behalf of the underlying applicants whose details are contained underlying applicants, 股份总数 in the read only CD-ROM submitted with this Application Form. offer to purchase 股香港公开发售股份 （代表相关申请人，其详细资料载於连同本申请表格递交的唯读光碟）。 吾等（代表相关 申请人） 要约购买 New Century Healthcare Holding Co. Limited 新 世 纪 医 疗 控 股 有 限 公 司 (incorporated in the Cayman Islands with limited liability) （於开曼群岛注册成立的有限公司） GLOBAL OFFERING 全 球 发 售 Number of Offer Shares under the Global Offering : 120,000,000 Shares (subject to the Over-Allotment Option) 全球发售的发售股份数目 ： 120,000,000股股份 （视乎超额配股权行使与否而定） Number of International Offer Shares : 108,000,000 Shares (subject to adjustment and the Over-Allotment Option) 国际发售股份数目 ： 108,000,000股股份 （可予调整及视乎超额配股权行使与否而定） Number of Hong Kong Public Offer Shares : 12,000,000 Shares (subject to adjustment) 香港公开发售股份数目 ： 12,000,000股股份 （可予调整） Maximum Offer Price : HK$8.36 per Offer Share, plus brokerage of 1%, SFC transaction levy of 0.0027%, and Hong Kong Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) 最高发售价 ： 每股发售股份8.36港元，另加1.0%经纪佣金、0.0027%证监会交易徵费及 0.005%香港联交所交易费 （须於申请时以港元缴足，多缴股款可予退还） Nominal value : US$0.0001 per Share 面值 ： 每股股份0.0001美元 Stock code : 1518 股份代号 ： 1518 For bank use 此栏供银行填写 Please read carefully the prospectus of New Century Healthcare Holding Co. Limited (the “Company”) dated December 30, 2016 (the “Prospectus”) (in particular, the section on “How to Apply for Hong Kong Public Offer Shares” in the Prospectus) and the guide on the back of this Application Form before completing this Application Form. Terms defined in the Prospectus have the same meaning when used in this Application Form unless defined herein. Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”), Hong Kong Securities Clearing Company Limited (“HKSCC”), the Securities and Futures Commission of Hong Kong (“SFC”) and the Registrar of Companies of Hong Kong take no responsibility for the contents of this Application Form, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of this Application Form. A copy of this Application Form, together with a copy of each of the WHITE and YELLOW Application Forms, the Prospectus and the other documents specified in the section headed “Documents Delivered to the Registrar of Companies and Available for Inspection �C Documents Delivered to the Registrar of Companies” in Appendix V to the Prospectus have been registered by the Registrar of Companies in Hong Kong as required by Section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). The SFC and the Registrar of Companies in Hong Kong take no responsibility as to the contents of any of these documents. Your attention is drawn to the paragraph headed “Personal Data” which sets out the policies and practices of the Company and the Hong Kong Share Registrar in relation to personal data and compliance with the Personal Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong Kong). Nothing in this Application Form or the Prospectus constitutes an offer to sell or a solicitation of an offer to buy nor shall there be any sale of Hong Kong Public Offer Shares in any jurisdiction other than Hong Kong. This Application Form and the Prospectus are not for distribution, directly or indirectly, in or into the United States, nor is this application an offer of Shares for sale in the United States. The Offer Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities law in the United States and may not be offered, sold, pledged or transferred within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. The Offer Shares are being offered and sold outside the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act and the applicable laws of each jurisdiction where those offers and sales occur. No public offering of the Offer Shares will be made in the United States. This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of that jurisdiction. This Application Form and the Prospectus are addressed to you personally. Any forwarding or distribution or reproduction of this Application Form or the Prospectus in whole or in part is unauthorized. Failure to comply with this directive may result in a violation of the Securities Act or the applicable laws of other jurisdictions. To: New Century Healthcare Holding Co. Limited Joint Sponsors Joint Global Coordinators The Hong Kong Underwriters 在填写本申请表格前，请细阅新世纪医疗控股有限公司 （ 「 本公司」） 於二零一六年十二月三十 日刊发的招股章程 （ 「 招股章程」）（尤其是招股章程 「如何申请香港公开发售股份」一节） 及刊於 本申请表格背面的指引。除非本申请表格另有定义，否则本申请表格所使用的词语与招股章 程所界定者具相同涵义。 香港交易及结算所有限公司、香港联合交易所有限公司 （ 「 香港联交所」） 、香港中央结算有限 公司 （ 「 香港结算」） 、香港证券及期货事务监察委员会 （ 「 证监会」） 及香港公司注册处处长对本 申请表格的内容概不负责，对其准确性或完整性亦不发表任何声明，并明确表示概不就因本 申请表格全部或任何部分内容而产生或因依赖该等内容而引致的任何损失承担任何责任。 本申请表格连同白色及黄色申请表格、招股章程及招股章程附录五 「送呈公司注册处处长及 备查文件－送呈公司注册处处长文件」 一节所列的其他文件，已遵照香港法例第32章《公司 （清盘及杂项条文） 条例》第342C条的规定，送呈香港公司注册处处长登记。证监会及香港公 司注册处处长对任何此等文件的内容概不负责。 阁下敬请留意 「个人资料」一段，当中载有本公司及其香港证券登记处有关个人资料及遵守香 港法例第486章 《个人资料（私隐） 条例》的政策及措施。 本申请表格或招股章程所载者概不构成出售要约或要约购买的游说，而在任何香港以外的司 法权区，概不得出售任何香港公开发售股份。本申请表格及招股章程不得在美国境内直接或 间接派发，而此项申请亦非在美国出售股份的要约。发售股份并无亦不会根据一九三三年美 国证券法（经修订）（ 「 美国证券法」） 或美国任何州证券法登记，且不得在美国境内发售、出 售、抵押或转让，惟根据美国证券法及适用美国州证券法获豁免登记规定或并非受该等登记 规定规限的交易除外。发售股份依据美国证券法S规例以及进行发售及出售的各司法权区适 用法例於离岸交易中在美国境外提呈发售及出售。不会於美国进行发售股份的公开发售。 在任何根据有关法律不得发送、派送或复制本申请表格及招股章程的司法权区，概不得以任 何方式发送或派发或复制 （全部或部分） 本申请表格及招股章程。本申请表格及招股章程仅致 予　阁下本人。概不得发送或派发或复制本申请表格或招股章程的全部或部分。如未能遵守 此项指令，可能违反证券法或其他司法权区的适用法律。 致： 新世纪医疗控股有限公司 联席保荐人 联席全球协调人 香港包销商 Signature 签名 Name of applicant 申请人名称 Date 日期 Capacity 身份 吾等确认，吾等已(i)遵守 《电子公开发售指引》及透过银行�u股票经纪递交白表eIPO 申请的运作程序以及与吾等就香港公开发售提供白表eIPO服务有关的所有适用法例 及规例 （不论法定或其他） ；及(ii)阅读招股章程及本申请表格所载条款及条件以及申 请手续，并同意受其约束。为了代表与本申请有关的每名相关申请人作出申请，吾 等： 按照招股章程及本申请表格的条款及条件，并在　贵公司组织章程细则规限 下，申请以下数目的香港公开发售股份； 夹附申请认购香港公开发售股份所需的全数款项（包括1%经纪佣金、 0.0027% 证监会交易徵费及0.005%香港联交所交易费） ； 确认相关申请人已承诺及同意接纳所申请认购的香港公开发售股份，或该等相 关申请人根据本申请获分配的任何较少数目的香港公开发售股份； 承诺及确认相关申请人及相关申请人为其利益而提出申请的人士并无申请或承 购或表示有意认购或收取或获配售或分配 （包括有条件及�u或暂定） ，亦不会申 请或承购或表示有意认购国际发售的任何发售股份，亦不会以其他方式参与国 际发售； 明白　贵公司及联席全球协调人将依赖此等声明及陈述，以决定是否就本申请 配发任何香港公开发售股份，及相关申请人如作出虚假声明，可能会遭受检 控； 授权　贵公司将相关申请人的名称列入　贵公司股东名册内，作为任何将配发 予相关申请人的香港公开发售股份的持有人，且　贵公司及�u或其代理可根据 本申请表格及招股章程所载程序按相关申请人的申请指示所指定地址以普通邮 递方式寄发任何股票 （如适用） ，邮误风险概由该相关申请人承担； 倘申请人使用单一银行账户支付申请股款，要求任何电子退款指示将发送至申 请付款账户内； 要求任何退款支票以使用不同银行账户支付申请股款的相关申请人为抬头人； 确认各相关申请人已阅读本申请表格及招股章程所载条款及条件以及申请手 续，并同意受其约束； 声明、保证及承诺向相关申请人或由相关申请人或为其利益而提出本申请的人 士配发或申请认购香港公开发售股份，不会引致　贵公司、联席全球协调人、 包销商或彼等各自的任何高级职员或顾问须遵从香港以外任何地区的法律或规 例 （不论是否具法律效力） 的任何规定；及 同意本申请、任何对本申请的接纳以及因而订立的合约，将受香港法律管辖及 按其诠释。 Sample 样版 Hong Kong Public Offering �C White Form eIPO Service Provider Application Form 香港公开发售－白表eIPO服务供应商申请表格 Please use this application form if you are a White Form eIPO Service Provider and are applying for Hong Kong Public Offer Shares on behalf of underlying applicants. 倘　阁下为白表eIPO服务供应商并代表相关申请人申请认购香港公开发售股份，请使用本申请表格。 GUIDE TO COMPLETING THIS APPLICATION FORM References to boxes below are to the numbered boxes on this Application Form. 1 Sign and date the application form in Box 1. Only a written signature will be accepted. The name and the representative capacity of the signatory should also be stated. To apply for Hong Kong Public Offer Shares using this Application Form, you must be named in the list of White Form eIPO Service Providers who may provide White Form eIPO services in relation to the Hong Kong Public Offering, which was released by the SFC. 2 Put in Box 2 (in figures) the total number of Hong Kong Public Offer Shares for which you wish to apply on behalf of the underlying applicants. Applicant details of the underlying applicants on whose behalf you are applying must be contained in one data file in read-only CD-ROM format submitted together with this Application Form. 3 Complete your payment details in Box 3. You must state in this box the number of cheque(s) you are enclosing together with this Application Form; and you must state on the reverse of each of those cheque(s) (i) your White Form eIPO Service Provider ID and (ii) the file number of the data file containing application details of the underlying applicant(s). The dollar amount(s) stated in this box must be equal to the amount payable for the total number of Hong Kong Public Offer Shares applied for in Box 2. All cheque(s) and this Application Form together with a sealed envelope containing the CD-ROM, if any, must be placed in the envelope bearing your company chop. For payments by cheque, the cheque must: be in Hong Kong dollars; be drawn on a Hong Kong dollar bank account in Hong Kong; show your (or your nominee’s) account name; be made payable to “HORSFORD NOMINEES LIMITED-NEW CENTURY HEALTHCARE PUBLIC OFFER”; be crossed “Account Payee Only”; not be post dated; and be signed by the authorized signatories of the White Form eIPO Service Provider. Your application may be rejected if any of these requirements is not met or if the cheque is dishonoured on its first presentation. It is your responsibility to ensure that details on the cheque(s) submitted correspond with the application details contained in the CD-ROM or data file submitted in respect of this application. The Company and the Joint Global Coordinators have full discretion to reject any applications in the case of discrepancies. No receipt will be issued for sums paid on application. 4 Insert your details in Box 4 (using BLOCK letters). You should write the name, ID and address of the White Form eIPO Service Provider in this box. You should also include the name and telephone number of the contact person at your place of business and where applicable, the Broker No. and Broker’s Chop. Personal Data Personal Information Collection Statement The main provisions of the Personal Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong Kong) (the “Ordinance”) came into effect in Hong Kong on December 20, 1996. This Personal Information Collection Statement informs the applicant for and holder of the Shares of the policies and practices of the Company and the Hong Kong Share Registrar in relation to personal data and the Ordinance. 1. Reasons for the collection of your personal data From time to time it is necessary for applicants for securities or registered holders of securities to supply their latest correct personal data to the Company or its agents and/or the Hong Kong Share Registrar when applying for securities or transferring securities into or out of their names or in procuring the services of the Hong Kong Share Registrar. Failure to supply the requested data may result in your application for securities being rejected or in delay or inability of the Company and/or the Hong Kong Share Registrar to effect transfers or otherwise render their services. It may also prevent or delay registration or transfer of the Hong Kong Public Offer Shares which you have successfully applied for and/or the dispatch of share certificate(s), and/or the dispatch of e-Refund payment instructions, and/or the dispatch of refund cheque(s) to which you are entitled. It is important that holders of securities inform the Company and the Hong Kong Share Registrar immediately of any inaccuracies in the personal data supplied. 2. Purposes The personal data of the applicants and the holders of securities may be used, held and/or stored (by whatever means) for the following purposes: processing of your application and e-Refund payment instructions/refund cheque, where applicable, and verification of compliance with the terms and application procedures set out in this form and the Prospectus and announcing results of allocation of the Hong Kong Public Offer Shares; enabling compliance with all applicable laws and regulations in Hong Kong and elsewhere; registering new issues or transfers into or out of the names of holders of securities including, where applicable, in the name of HKSCC Nominees; maintaining or updating the registers of holders of securities of the Company; conducting or assisting to conduct signature verifications, any other verification or exchange of information; establishing benefit entitlements of holders of securities of the Company, such as dividends, rights issues and bonus issues, etc; distributing communications from the Company and its subsidiaries; compiling statistical information and Shareholder profiles; making disclosures as required by laws, rules or regulations; disclosing identities of successful applicants by way of press announcement(s) or otherwise; disclosing relevant information to facilitate claims on entitlements; and any other incidental or associated purposes relating to the above and/or to enable the Company and the Hong Kong Share Registrar to discharge their obligations to holders of securities and/or regulators and/or any other purpose to which the holders of securities may from time to time agree. 3. Transfer of personal data Personal data held by the Company and the Hong Kong Share Registrar relating to the holders of securities will be kept confidential but the Company and the Hong Kong Share Registrar may, to the extent necessary for achieving the above purposes or any of them, make such enquiries as they consider necessary to confirm the accuracy of the personal data and in particular, they may disclose, obtain, transfer (whether within or outside Hong Kong) the personal data of the holders of securities to, from or with any and all of the following persons and entities: the Company or its appointed agents such as financial advisers, the receiving banks and overseas principal registrars; where applicants for securities request deposit into CCASS, to HKSCC and HKSCC Nominees, who will use the personal data for the purposes of operating CCASS; any agents, contractors or third-party service providers who offer administrative, telecommunications, computer, payment or other services to the Company and/or the Hong Kong Share Registrar in connection with the operation of their respective businesses; the Hong Kong Stock Exchange, the SFC and any other statutory, regulatory or governmental bodies; and any other persons or institutions with which the holders of securities have or propose to have dealings, such as their bankers, solicitors, accountants or stockbrokers, etc. 4. Retention of personal data The Company and the Hong Kong Share Registrar will keep the personal data of the applicants and holders of securities for as long as necessary to fulfil the purposes for which the personal data were collected. Personal data which is no longer required will be destroyed or dealt with in accordance with the Ordinance. 5. Access and correction of personal data The Ordinance provides the holders of securities with rights to ascertain whether the Company or the Hong Kong Share Registrar hold their personal data, to obtain a copy of that data, and to correct any data that is inaccurate. In accordance with the Ordinance, the Company and the Hong Kong Share Registrar have the right to charge a reasonable fee for the processing of any data access request. All requests for access to data or correction of data or for information regarding policies and practices and the kinds of data held should be addressed to the Company at its registered office disclosed in the “Corporate Information” section in the Prospectus or as notified from time to time in accordance with applicable law, for the attention of the company secretary or (as the case may be) the Hong Kong Share Registrar for the attention of the privacy compliance officer for the purposes of the Ordinance. By signing this form, you agree to all of the above. 填写本申请表格的指引 下文提述的号码乃本申请表格中各栏的编号。 1 在申请表格栏1签署及填上日期。仅接受亲笔签名。 签署人的名称及代表身份亦必须注明。 如要使用本申请表格申请香港公开发售股份，　阁下必须为名列於证监会公布 的白表eIPO服务供应商名单内可以就香港公开发售提供白表e IPO服务的人 士。 2 在栏2填上　阁下欲代表相关申请人申请认购的香港公开发售股份总数 （请填写 数字）。 阁下代其作出申请的相关申请人资料，必须载於连同本申请表格递交的一个唯 读光碟格式资料档案内。 3 在栏3填上　阁下付款的详细资料。 阁下必须在此栏注明　阁下连同本申请表格夹附的支票数目；并在每张支票的 背面注明(i) 阁下的白表eIPO服务供应商身份证明号码及(ii)载有相关申请人申 请详细资料的资料档案的档案编号。 此栏所注明的金额必须与栏2所申请认购的香港公开发售股份总数应付的金额 相同。 所有支票及本申请表格，连同载有该唯读光碟的密封信封（如有） 必须放进盖 上　阁下公司印章的信封内。 如以支票缴付股款，该支票必须： 为港元支票； 以在香港开设的港元银行账户开出； 显示　阁下 （或　阁下代名人） 的账户名称； 注明抬头人为 「 浩丰代理人有限公司－新世纪医疗公开发售」； 以 「只准入抬头人账户」划线方式开出； 不得为期票；及 由白表eIPO服务供应商的授权签署人签署。 倘未能符合任何此等规定或倘支票首次过户不获兑现，　阁下的申请可遭拒绝 受理。 阁下有责任确保所递交的支票上的详细资料与就本申请递交的唯读光碟或资料 档案所载的申请详细资料相同。 倘出现差异，本公司及联席全球协调人有绝对酌情权拒绝任何申请。 申请时缴付的款项将不会获发收据。 4 在栏4填上　阁下的详细资料（用正楷填写）。 阁下必须在此栏填上白表eIPO服务供应商的名称、身份证明号码及地址。　阁 下亦必须填写　阁下营业地点的联络人士的名称及电话号码及 （如适用） 经纪号 码及加盖经纪印章。 个人资料 个人资料收集声明 香港法例第486章《个人资料（私隐） 条例》（ 「 《条例》」） 中的主要条文於一九九 六年十二月二十日在香港生效。此项个人资料收集声明是向股份申请人及持 有人说明本公司及其香港证券登记处有关个人资料及《条例》方面的政策及措 施。 1. 收集　阁下个人资料的原因 证券申请人或证券登记持有人申请证券或将证券转往其名下，或将名下 证券转让予他人，或要求香港证券登记处提供服务时，须不时向本公司 或其代理及�u或香港证券登记处提供其最新的准确个人资料。 未能提供所要求的资料可能导致　阁下的证券申请被拒绝或延迟， 或本公司及�u或香港证券登记处无法落实证券转让或提供服务。此 举亦可能妨碍或延迟登记或转让　阁下获接纳申请的香港公开发售 股份及�u或寄发股票及�u或发送电子退款指示及�u或寄发　阁下应 得的退款支票。 证券持有人所提供的个人资料如有任何错误，须立即通知本公司及香港 证券登记处。 2. 目的 证券申请人及持有人的个人资料可作以下用途使用、持有及�u或保存： 处理　阁下的申请及电子退款指示�u退款支票 （如适用） 及核实是 否符合本表格及招股章程所载条款及申请手续及公布香港公开发 售股份的分配结果； 使香港及其他地区的所有适用法律及法规得到遵守； 以证券持有人 （包括以香港结算代理人 （如适用）） 的名义登记新发 行证券或转让或受让证券； 存置或更新本公司证券持有人的名册； 进行或协助进行签名核对、任何其他核对或交换资料； 确定本公司证券持有人的受益权利，如股息、供股及红股等； 分发本公司及其附属公司的公司通讯； 编制统计资料及股东资料； 遵照法例、规则或规例的要求作出披露； 透过报章公布或其他方式披露获接纳申请人士的身份； 披露有关资料以便就权益提出申索；及 与上述者有关的任何其他附带或相关用途及�u或使本公司及香港 证券登记处能履行对证券持有人及�u或监管机构承担的责任及�u 或证券持有人不时同意的任何其他用途。 3. 转交个人资料 本公司及香港证券登记处会对证券持有人的个人资料保密，但本公司及 香港证券登记处可在将资料用作上述用途的必要情况下作出彼等认为必 要之查询以确定个人资料的准确性，尤其可能会向下列任何及所有人士 及机构披露、获取或转交证券持有人的个人资料（无论在香港境内或境 外） ： 本公司或其委任的代理，如财务顾问、收款银行及海外主要证券 登记处； （如证券申请人要求将证券存於中央结算系统） 香港结算或香港结 算代理人，彼等将会就中央结算系统的运作使用有关个人资料； 向本公司及�u或香港证券登记处提供与其各自业务运作有关的行 政、电讯、电脑、付款或其他服务的任何代理、承办商或第三方 服务供应商； 香港联交所、证监会及任何其他法定、监管或政府机关；及 证券持有人与其进行或拟进行交易的任何其他人士或机构，如其 银行、律师、会计师或股票经纪等。 4. 个人资料的保留 本公司及香港证券登记处将按收集个人资料所需的用途保留证券申请人 及持有人的个人资料。无需保留的个人资料将会根据《条例》销毁或处 理。 5. 查阅及更正个人资料 《条例》赋予证券持有人权利以确定本公司或香港证券登记处是否持有其 个人资料、索取有关资料副本及更正任何不准确之资料。根据 《条例》规 定，本公司及香港证券登记处有权就处理任何查阅资料的要求收取合理 费用。所有关於查阅资料或更正资料或查询有关政策及措施的资料及所 持有资料类别的要求，应按照招股章程 「公司资料」一节中披露的本公司 注册办事处或根据适用法律不时通知的地址，向本公司的公司秘书或香 港证券登记处属下就《条例》所指的个人资料私隐事务主任（视乎情况而 定） 提出。 阁下签署本表格，即表示同意上述所有规定。 DELIVERY OF THIS APPLICATION FORM This completed Application Form, together with the appropriate cheque(s) and a sealed envelope containing the CD-ROM, must be submitted to the following receiving bank by 4:00 p.m. on Wednesday, January 11, 2017: Standard Chartered Bank (Hong Kong) Limited 15/F Standard Chartered Tower 388 Kwun Tong Road Kwun Tong 递交本申请表格 经填妥的本申请表格，连同相关支票及载有唯读光碟的密封信封，必须於二零一七年 一月十一日 （星期三） 下午四时正前，送达以下收款银行： 渣打银行 （香港）有限公司 观塘 观塘道388号 渣打中心15楼 Sample 样版